Preoperative MRI-based predictive model for biochemical recurrence following radical prostatectomy.
1/5 보강
PICO 자동 추출 (휴리스틱, conf 3/4)
유사 논문P · Population 대상 환자/모집단
170 patients who underwent RP between January 2015 and December 2022.
I · Intervention 중재 / 시술
RP between January 2015 and December 2022
C · Comparison 대조 / 비교
추출되지 않음
O · Outcome 결과 / 결론
Our new model exhibits superior predictive accuracy with respect to BCRFS relative to the basic model. Apart from tumor features, pelvic anatomical features should also be considered before the treatment decision making of PCa patients.
[PURPOSE] To determine the biochemical recurrence (BCR)-related pelvic anatomic characteristics before radical prostatectomy (RP) and to establish a new predictive model for BCR-free survival (BCRFS).
- p-value p < 0.05
- p-value p < 0.001
APA
Peng Q, Xu L, et al. (2025). Preoperative MRI-based predictive model for biochemical recurrence following radical prostatectomy.. Abdominal radiology (New York), 50(10), 4687-4699. https://doi.org/10.1007/s00261-025-04877-0
MLA
Peng Q, et al.. "Preoperative MRI-based predictive model for biochemical recurrence following radical prostatectomy.." Abdominal radiology (New York), vol. 50, no. 10, 2025, pp. 4687-4699.
PMID
40100279 ↗
Abstract 한글 요약
[PURPOSE] To determine the biochemical recurrence (BCR)-related pelvic anatomic characteristics before radical prostatectomy (RP) and to establish a new predictive model for BCR-free survival (BCRFS).
[METHODS] The study involved 170 patients who underwent RP between January 2015 and December 2022. Kaplan-Meier plots were applied to estimate survival probabilities. Multivariate Cox regression models were employed to identify predictors for BCRFS, which were subsequently incorporated into an MRI-based nomogram to visualize the model. The Harrell's concordance index (C-index) was employed to evaluate the discrimination, and compared with a basic model without incorporating pelvic anatomy. Time-dependent receiver operating characteristic (ROC) curves and decision curve analysis (DCA) were applied to identify the advantage of the new predictive model. Three risk categories were created.
[RESULTS] Multifactorial analysis revealed that age, capsule contact length (CCL), tumor's distance to the proximal membranous urethra (UD), urethral width, and annual surgery volume were independent risk factors for BCR (all p < 0.05). The established predictive model yielded a C-index of 0.850 that was superior to aforementioned basic model with C-index of 0.771 (p < 0.001). Our new model with an area under the ROC curve (AUC) of 0.893 revealed better predictive ability in BCRFS than basic model with the AUC of 0.823 (p = 0.01), and DCA demonstrated that our model generated more net benefits.
[CONCLUSION] UD and urethral width are independent predictors of BCRFS. Our new model exhibits superior predictive accuracy with respect to BCRFS relative to the basic model. Apart from tumor features, pelvic anatomical features should also be considered before the treatment decision making of PCa patients.
[METHODS] The study involved 170 patients who underwent RP between January 2015 and December 2022. Kaplan-Meier plots were applied to estimate survival probabilities. Multivariate Cox regression models were employed to identify predictors for BCRFS, which were subsequently incorporated into an MRI-based nomogram to visualize the model. The Harrell's concordance index (C-index) was employed to evaluate the discrimination, and compared with a basic model without incorporating pelvic anatomy. Time-dependent receiver operating characteristic (ROC) curves and decision curve analysis (DCA) were applied to identify the advantage of the new predictive model. Three risk categories were created.
[RESULTS] Multifactorial analysis revealed that age, capsule contact length (CCL), tumor's distance to the proximal membranous urethra (UD), urethral width, and annual surgery volume were independent risk factors for BCR (all p < 0.05). The established predictive model yielded a C-index of 0.850 that was superior to aforementioned basic model with C-index of 0.771 (p < 0.001). Our new model with an area under the ROC curve (AUC) of 0.893 revealed better predictive ability in BCRFS than basic model with the AUC of 0.823 (p = 0.01), and DCA demonstrated that our model generated more net benefits.
[CONCLUSION] UD and urethral width are independent predictors of BCRFS. Our new model exhibits superior predictive accuracy with respect to BCRFS relative to the basic model. Apart from tumor features, pelvic anatomical features should also be considered before the treatment decision making of PCa patients.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
같은 제1저자의 인용 많은 논문 (5)
- Habitat-based CT radiomics profiling spatial-temporal heterogeneity in resectable NSCLC predict pathological response to neoadjuvant chemoimmunotherapy: a multi-center study.
- Mast cell-derived MIF Polarizes Th17 cells to drive lung adenocarcinoma progression.
- Application Value of Prostate-Specific Magnetic Resonance Imaging Features Combined with Nonspecific Serum Markers in Risk Stratification of Clinically Significant Prostate Cancer.
- Long noncoding RNA RHPN1-AS1 promotes hepatocellular carcinoma progression under hypoxia through interaction with RPS15A protein.
- Integrated single-cell and bulk RNA sequencing analyses identify an immunotherapy nonresponse-related fibroblast signature in gastric cancer.
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results.
- Self-management of male urinary symptoms: qualitative findings from a primary care trial.
- Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years.
- Diagnostic accuracy of Ga-PSMA PET/CT versus multiparametric MRI for preoperative pelvic invasion in the patients with prostate cancer.
- Comprehensive analysis of androgen receptor splice variant target gene expression in prostate cancer.
- Clinical Presentation and Outcomes of Patients Undergoing Surgery for Thyroid Cancer.